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Nuclear cardiology is one of the principal branches of nuclear
medicine for two reasons: firstly, heart diseases are the main cause
of death in developing countries, secondly, the rapid development
of cardiac surgery as well as angioplasty, laser myocardial therapy
etc. stimulates the growing demand for non-invasive diagnostic
techniques. The number of nuclear cardiac studies is growing con-
tinuously, as a functional supplement to angiography, as well as
being a predictor of the success of intervention, an important tool
in assessing myocardial viability and in post-intervention follow-up.
Therefore, this interesting and very well illustrated atlas meets
the needs of both cardiologists and nuclear medicine specialists.
It will be probably a great help in the everyday work of nuclear
cardiologists. It is printed on a very good paper, and the quality
of the reproduced images is excellent.
The atlas has 68 pages, 34 illustrations and the text is in Czech
and English. In the 16 page introduction, radiopharmaceuticals
(SPECT and PET), stress techniques, SPECT imaging interpreta-
tion and indications for myocardial perfusion imaging are all dis-
cussed. This section would be even better if the mutual relations
with radiological techniques were outlined and discussed, in par-
ticular the superiorities and inferiorities of radionuclide methods
versus angiographic and MRI modalities. This would give nuclear
medicine specialists a tool to use in arguments with fellow cardio-
logists and radiologists. Both in the Indications section and in the
illustrated part, it could have been useful to have mentioned the
important role of radionuclide studies in the evaluation of coro-
nary heart disease with negative angiographic findings.
The illustrated part of the book shows the images of normal
findings, attenuation artefacts, examples of single-vessel and multi-
vessel coronary artery disease SPECT studies, post-infarction im-
ages, post-PTCA and post-CABG images, cardiomyopathy and
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myocardial viability studies. These examples are well chosen and
excellently illustrated.
This part could have benefited from showing some more cardi-
ac PET studies (three 18FDG SPECT are included in the paragraph
on myocardial viability). Positron emitting radiopharmaceuticals are
mentioned briefly in the introduction (paragraph 2.2), but the authors
do not carry this issue any further. That is a pity, as the role of PET,
especially in the assessment of myocardial viability, is increasing.
Unfortunately, the literature overview does not, with three ex-
ceptions, cover positions published later then 1999.
Despite these minor drawbacks, the authors should be highly
praised for their efforts in publishing this book and special con-
gratulations should be paid to Lacomed Ltd. for their role in this
contribution to education. This Czech radiopharmaceutical man-
ufacturer is running, at least in this part of Europe, an interesting
and unique educational scheme by supporting publications like
this. As far as I remember, this is their fifth publication of this type,
following ones on gallium scintigraphy, samarium-153 therapy,
renal disorders and PET. I wish such publications could be pro-
duced, for example, here in Poland.
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Few people know that the history of Positron Emission
Tomography dates back to 1951 and that the first imaging devices
of PET have their origins in the sixties. The interesting historical
introduction in this atlas gives the reader a fascinating view of the
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illustrated overview of PET applications. This technique actually
started its march as late as the 1990s, less scientific like before,
but on more and more clinical applications.
The Czech Republic has become one of the most important,
if not the most important PET centre in Central Europe. Historical-
ly, the first PET centre in Central Europe was established in
Debrecen (Hungary). A PET centre is also located in Bratislava
(Slovakia) and a newly established one is in Bydgoszcz (Poland).
However, two PET units in Prague and a third one in Brno make
the Czech Republic No. 1 in PET in the region.
This atlas by Belohlávek et al. is a summary of four years
experience in “Na Homolce” PET Centre. It has 72 pages, de-
scribes 52 well-chosen cases of PET application and the text is in
Czech and English.
In the 19 page introduction, the authors describe the history
and physical aspects of PET, data acquisition and processing,
the pharmaco-kinetics of 18F-DG and the normal pattern of FDG
uptake. Perhaps the authors should have dedicated a paragraph
to radiopharmaceuticals other than FDG and radioisotopes other
than 18F (this issue is briefly mentioned on page 65), but I under-
stand that the book is focused on the most popular radiopharma-
ceutical in use, which is FDG.
The illustrated section of the book shows images of the nor-
mal pattern of FDG uptake, brain, head and neck tumours, lung
diseases — malignant and benign (pneumonia) findings, GI tu-
mours, urogenital tumours, breast cancer, endocrine tumours,
sarcomas, lymphomas, inflammation, epilepsy and an assess-
ment of myocardial viability. The quality of paper and illustrations
is very good. At the end of each paragraph a brief summary
of clinical considerations is to be found.
Something both very pleasant and admirable is the objectivity
of the authors. It is very easy to fall into the trap of unconditional
enthusiasm for our own concepts; as Sir Robert Millikan, the physi-
cist, once said “Never fall in love with your theory”. Fortunately,
the authors did not. When FDG PET fails, e.g. in distinguishing
tumours and inflammation, it is admitted with objectivity and hon-
esty. This is also seen in the summaries mentioned above. Chap-
ter 7 — “Decalogue of oncological (PET) indications” is written
transparently and self-critically, showing  both common sense and
a self-deprecatory sense of humour.
One minor remark — the atlas is almost entirely lacking refer-
ences. The authors mention 32,000 positions under the key-word
PET in MEDLINE at the beginning of 2003 (page 9).
Therefore, why did they not cite some of them?
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